Skip to Content

Drug Interactions between phenolphthalein and sibutramine

This report displays the potential drug interactions for the following 2 drugs:

  • phenolphthalein
  • sibutramine

Edit list (add/remove drugs)

Interactions between your drugs

No interactions were found between phenolphthalein and sibutramine. This does not necessarily mean no interactions exist. Always consult your healthcare provider.

phenolphthalein

A total of 201 drugs are known to interact with phenolphthalein.

  • Phenolphthalein is in the drug class laxatives.

sibutramine

A total of 525 drugs are known to interact with sibutramine.

Drug and food interactions

Moderate

sibutramine food

Applies to: sibutramine

Using sibutramine with alcohol can increase the risk of cardiovascular side effects such as increased heart rate, chest pain, or blood pressure changes. In addition, you may also be more likely to experience nervous system side effects such as dizziness, drowsiness, depression, and difficulty concentrating. You should avoid or limit the use of alcohol while being treated with sibutramine. Do not use more than the recommended dose of sibutramine, and avoid activities requiring mental alertness such as driving or operating hazardous machinery until you know how the medication affects you. It is important to tell your doctor about all other medications you use, including vitamins and herbs. Do not stop using any medication without first talking to your doctor.

Switch to professional interaction data

Therapeutic duplication warnings

No warnings were found for your selected drugs.

Therapeutic duplication warnings are only returned when drugs within the same group exceed the recommended therapeutic duplication maximum.

Drug Interaction Classification

These classifications are only a guideline. The relevance of a particular drug interaction to a specific individual is difficult to determine. Always consult your healthcare provider before starting or stopping any medication.
Major Highly clinically significant. Avoid combinations; the risk of the interaction outweighs the benefit.
Moderate Moderately clinically significant. Usually avoid combinations; use it only under special circumstances.
Minor Minimally clinically significant. Minimize risk; assess risk and consider an alternative drug, take steps to circumvent the interaction risk and/or institute a monitoring plan.
Unknown No interaction information available.

Further information

Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.